1. Home
  2. PDX vs QURE Comparison

PDX vs QURE Comparison

Compare PDX & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PIMCO Dynamic Income Strategy Fund of Beneficial Interest

PDX

PIMCO Dynamic Income Strategy Fund of Beneficial Interest

HOLD

Current Price

$20.47

Market Cap

904.4M

Sector

Finance

ML Signal

HOLD

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$17.59

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDX
QURE
Founded
2019
1998
Country
NY
Netherlands
Employees
N/A
248
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
904.4M
1.1B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
PDX
QURE
Price
$20.47
$17.59
Analyst Decision
Buy
Analyst Count
0
14
Target Price
N/A
$44.92
AVG Volume (30 Days)
140.7K
1.6M
Earning Date
01-01-0001
05-08-2026
Dividend Yield
4.95%
N/A
EPS Growth
N/A
29.67
EPS
N/A
N/A
Revenue
N/A
$13,107,000.00
Revenue This Year
N/A
$126.12
Revenue Next Year
N/A
$200.43
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.47
$8.73
52 Week High
$25.25
$71.50

Technical Indicators

Market Signals
Indicator
PDX
QURE
Relative Strength Index (RSI) 38.90 53.07
Support Level $19.95 $13.47
Resistance Level $22.29 $18.37
Average True Range (ATR) 0.45 1.33
MACD -0.15 0.27
Stochastic Oscillator 3.39 87.86

Price Performance

Historical Comparison
PDX
QURE

About PDX PIMCO Dynamic Income Strategy Fund of Beneficial Interest

PIMCO Dynamic Income Strategy Fund is a non-diversified, limited-term, closed-end management investment company. It seeks current income as a primary objective and capital appreciation as a secondary objective. The fund makes investments using a dynamic asset allocation plan among multiple sectors in the public and private credit markets globally, including corporate debt, mortgage-related and other asset-backed instruments, government and sovereign debt, taxable municipal bonds, and other fixed, variable, and floating-rate income-producing securities of U.S. and foreign issuers, including emerging market issuers and real estate-related investments.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Share on Social Networks: